Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | IM |
The patient missed second dose of Rabavert vaccine; Case reference number US-BN-2024-002919 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-3348) on 19-Dec-2024 and concerns a 31-years-old male patient. The patient's medical history and concomitant medication details were not provided. On 15-Dec-2024, the patient took first dose of RabAvert along with device constituents prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at unknown dose and site of administration, intramuscularly, for post exposure prophylaxis. As reported the patient missed second dose of RabAvert which was due on 18-Dec-2024. (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert. No further information was provided.; Reporter's Comments: A 31-years-old male patient missed second dose of RabAvert which was due on 18-Dec-2024 and that is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to RabAvert. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 31-years-old male patient missed second dose of RabAvert which was due on 18-Dec-2024 and that is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to RabAvert. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None.